Should Contrast-Enhanced Harmonic Endoscopic Ultrasound Be Incorporated into the International Consensus Guidelines to Determine the Appropriate Treatment of Intraductal Papillary Mucinous Neoplasm?
Authors:
- Tomohiro YamazakiTYTomohiro Yamazaki
- Mamoru TakenakaMamoru Takenaka
- Shunsuke OmotoSOShunsuke Omoto
- Tomoe YoshikawaTYTomoe Yoshikawa
- Rei IshikawaRIRei Ishikawa
- Ayana OkamotoAOAyana Okamoto
- Atsushi NakaiANAtsushi Nakai
- Kosuke MinagaKMKosuke Minaga
- Ken KamataKKKen Kamata
- Kentaro YamaoKYKentaro Yamao
- Yoriaki KomedaYoriaki Komeda
- Tomohiro WatanabeTWTomohiro Watanabe
Open Access
- 22 April 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (9) , 1818
Abstract
This study aimed to investigate whether the incorporation of contrast-enhanced harmonic endoscopic ultrasound (CH-EUS) into the international consensus guidelines (ICG) for the management of intraductal papillary mucinous neoplasm (IPMN) could improve its malignancy diagnostic value. In this single-center retrospective study, 109 patients diagnosed with IPMN who underwent preoperative CH-EUS between March 2010 and December 2018 were enrolled. We analyzed each malignancy diagnostic value (sensitivity (Se), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV)) by replacing fundamental B-mode EUS with CH-EUS as the recommended test for patients with worrisome features (WF) (the CH-EUS incorporation ICG) and comparing the results to those obtained using the 2017 ICG. The malignancy diagnostic values as per the 2017 ICG were 78.9%, 42.3%, 60.0%, and 64.7% for Se, Sp, PPV, and NPV, respectively. The CH-EUS incorporation ICG plan improved the malignancy diagnostic values (Se 78.9%/Sp, 53.8%/PPV, 65.2%/NPV 70.0%). CH-EUS may be useful in determining the appropriate treatment strategies for IPMN.Keywords
This publication has 31 references indexed in Scilit:
- Utility of endoscopic ultrasound and endoscopic ultrasound‐guided fine‐needle aspiration for the diagnosis and management of pancreatic cystic lesions: Differences between the guidelinesDigestive Endoscopy, 2019
- Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreasPancreatology, 2017
- A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic CystsGastroenterology, 2015
- Evaluation of the Sendai and 2012 International Consensus Guidelines based on cross-sectional imaging findings performed for the initial triage of mucinous cystic lesions of the pancreas: a single institution experience with 114 surgically treated patientsThe American Journal of Surgery, 2014
- Peritoneal seeding in intraductal papillary mucinous neoplasm of the pancreas patients who underwent endoscopic ultrasound-guided fine-needle aspiration: The PIPE StudyEndoscopy, 2014
- International consensus guidelines 2012 for the management of IPMN and MCN of the pancreasPancreatology, 2012
- Surgical Outcome of Intraductal Papillary Mucinous Neoplasms of the PancreasAnnals of Surgical Oncology, 2007
- International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the PancreasPancreatology, 2006
- Intraductal Papillary Mucinous Neoplasms of the PancreasAnnals of Surgery, 2004
- Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinomaGut, 2002